X0609 4 2026-09-30 0 0001835268 Connect Biopharma Holdings Ltd CNTB 0002115875 Xanthopoulos Kleanthis Gabriel false 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130 1 0 0 0 0 Ordinary Shares 2026-09-30 4 A 0 5000 0 A 91554 D In accordance with the Connect Biopharma Holdings Limited Non-Employee Director Compensation Program, Dr. Xanthopoulos elected to receive fully vested shares in lieu of a portion of cash compensation for his 2026 annual board retainers. Accordingly, the fully vested ordinary shares were granted to Dr. Xanthopoulos for his service as a director during the third quarter of 2026. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our ordinary shares for the 30 days preceding September 30, 2026, rounded down to the nearest whole share. /s/ Lisa Peraza attorney-in-fact for Kleanthis Xanthopoulos 2026-10-01